The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a ...

Early proof-of-concept study showed that a patch pump with integrated glucose sensing at the site of insulin delivery can ...

Please provide your email address to receive an email when new articles are posted on . Mean sensor glucose and time in range improved slightly with a 1-year implantable CGM sensor compared with a 180 ...

With a single sensor, the Eversense 365 system provides one year of use, versus 10-14 days with short-term CGM’s for minimal life disruption “Managing diabetes can be stressful and it is important for ...

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...

Dexcom G7 CGMs contain a complex electronic assembly within a wearable package that stands up to the rigors of everyday ...

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship G7 sensor. The new system, which boosts wear time up from the previous ...

Concerns over Abbott's glucose monitoring devices highlight the urgent need for improved customer complaint redressal ...

A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose ...

Continuous glucose monitoring in the GRADE trial shows that incretin-based drugs such as sitagliptin and liraglutide produce the most stable glycemic profiles and show the lowest hypoglycemia risk.